By Jamie Freed and Sophie Yu SYDNEY/BEIJING (Reuters) – Chinese airlines will be the early winners of the country’s international…
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug
By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Food and Drug Administration failed to adhere to its own guidance and…
Novartis to pay $245 million to end antitrust cases over Exforge drug generics
By Jonathan Stempel NEW YORK (Reuters) -Novartis AG said on Wednesday it will pay $245 million to end antitrust litigation…
Hershey sued over chocolate containing heavy metals
By Jonathan Stempel NEW YORK (Reuters) – Hershey Co has been sued by a consumer who accused the company of…
Gilead buys out rights to cancer therapy from Jounce for $67 million
(Reuters) – Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for…
Analysis-China’s services sector eyes recovery after reopening, but challenges loom
By Joe Cash and Engen Tham BEIJING/SHANGHAI (Reuters) – Jordan Li, a restaurant owner in the southwestern Chinese city of…
Twitter restores suicide prevention feature after Reuters report
By Kenneth Li, Paresh Dave and Sheila Dang NEW YORK (Reuters) -Twitter Inc has restored a feature that promotes suicide…
Hungary imposes windfall tax on drug producers to plug budget gap
BUDAPEST (Reuters) -Hungary’s government has imposed a windfall tax on drug producers based on net revenues generated in 2022 and…
Exclusive-Twitter removes suicide prevention feature, says it’s under revamp
By Paresh Dave, Fanny Potkin and Sheila Dang (Reuters) -Twitter Inc removed a feature in the past few days that…
U.S. judge penalizes 3M, bars it from shifting liability in earplug litigation
By Nate Raymond (Reuters) – A U.S. judge on Thursday barred 3M Co from trying to avoid liability for injuries…